HOXC13 and central nervous system cancer: The discovery of the HOXC13-AS–miR-122-5p–SATB1–c-Myc feedback loop has improved the regulatory mechanism of HOXC13-AS in malignant tumors and provided potential therapeutic targets for gliomas (Liu et al., 2019).